Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you. =)
Agreed. Full transparency, I'm in $ACBFF, as well as $OWCP and $CNBX, and feel strongly they'll all do as you said... go way up.
Will shareholders in ACBFF auto-switch to ACB?
This is a GREAT buy-in opportunity, not just a decent one. As Money, Moxa1, Stockfan, and others have said-- the science, research, and management team are strong. This will pay off in short order.
CNBX Announces Positive Results for Pilot Study on Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)Preliminary findings showed more than 80 percent of patients had increase in appetite and 60 percent of patients had over 10 percent weight increase.
https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-announces-positive-results-for-pilot-study-on-treatment-of-cancer-anorexia-cachexia-syndrome-cacs-300731790.html
Agreed Moxa. Any day, any time = positive news.
NY Times: U.K. to Allow Medical Cannabis Rx Nov. 1
https://www.nytimes.com/2018/10/11/world/europe/uk-medical-cannabis.html
NY Times: U.K. to Allow Medical Cannabis Rx Nov. 1
https://www.nytimes.com/2018/10/11/world/europe/uk-medical-cannabis.html
OWC Pharmaceuticals is Progressing a Cannabis Ointment to Treat Psoriasis... from a few days ago:
https://www.equities.com/news/israel-s-owc-pharmaceuticals-is-progressing-a-cannabis-ointment-to-treat-psoriasis?platform=hootsuite
Dr. Gil Bar-Sela is scheduled this coming Monday, to present his findings at the 3rd International Medical Cannabis Conference. This Conference is held for global leaders in areas of Medical Cannabis to convene, explore and present the latest scientific and clinical research in medical cannabis, held in Tel Aviv from October 14th-16th, 2018.
Dr. Bar-Sela is the Deputy Director of the Division of Oncology at Rambam Health Care Campus, Head of the Palliative and Supportive Oncology Unit, and Head of the service for Melanoma and Sarcoma patients.
Dr. Bar-Sela has vast knowledge and experience in clinical evaluation of medical cannabis benefits to Cancer patients. Dr. Bar-Sela was the principal investigator of the company's clinical study, the first meaningful scientific study regarding the dosage and treatment regimen in oral administration of cannabis and the benefits in treating CACS in Cancer patients. While briefly noted in the Company's press release of July 3rd, 2018; this will be the first public scientific presentation of the results of this pilot study.
While this Clinical Study was conducted at Rambam Hospital in Israel, it is registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at https://clinicaltrials.gov/ct2/show/NCT02359123
Dr. Bar-Sela's Lecture is scheduled for Monday, October 15th, 2018, and entitled "OPENING THE GATES TO NEW CLINICAL RESEARCH."
https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-to-present-results-of-clinical-trial-at-international-medical-cannabis-conference-300716750.html
The true value is $1.00+ and will get there as soon as the end of the month. When the big news hits, this'll be worth a ton. That's not a pumping comment, but rather DD as I see it.
More from OwnTheFloat...
Definitely. My 'out-of-the-box' DD has me fairly confident that it'll see legitimately big gains. I can never gauge the OTC market, but even the upcoming Phase 1 data alone could ignite another silly run that may not hold "long term", but progress will keep being made.
— OwnTheFloat.com (@OwnTheFloat) October 4, 2018
Great buy in opportunity. Overbought/Undervalued and that's an honest opinion based on DD. Not pumping... I don't have that kind of sway. :)
Great news Moxa, thx =)
Thank you very, very much!
I'm going to be a Grandfather for the 1st time! I just found out. I pray you're right Moxa! Please run way up OWCP!
Moxa, others... what would be a realistic PPS if the Phase II results come back positive here in the 4th quarter, as expected?
OWCP feels like a spring about to be sprung.
Forgive my memory... the 4th quarter starts today. I always have trouble remembering how many days are in certain months.
4th quarter begins tomorrow. Good days ahead.
Yes! "DEA takes some CBD off Schedule 1 – with FDA’s approval"
https://hempindustrydaily.com/dea-takes-cbd-off-schedule-1-with-fdas-approval/
https://www.drugtargetreview.com/news/33869/cbd-improves-cancer/ "Mice with pancreatic cancer that were treated with CBD alongside chemotherapy, survived almost three times longer than those treated with chemotherapy alone" Just saw this article for the first time... impressive, to say the least. $OWCP
This is about to go up to .19-.20 by end of day. Put me on ignore if I'm wrong.
Agreed, great long-term news. This will rise over time back over a dollar and eventually be worth substantially more.
The conference in 3 weeks is big. As you said, more eyes, but more importantly, it's whose eyes they are. This latest cancer news is looming large.
Cancer, folks. This company broke news that its proprietary cannabinoid compounds are causing a higher rate of "cancer cell death" compared to traditional chemotherapy. When the trials are ended and this goes forward, we're talking an incredible valuation. In the meantime, once the bouncing down and up settles, we'll likely set up in the 1.20-1.40 area, until more positive news breaks. Once that happens... previous highs will be tested.
Big update 11:06 EST today, 9/18/18 "Eroll Grow Tech (SEEDO) Merges Its Activities With GRCR Partners; Cannabics Pharmaceuticals to Own 13.6% in the Merged Co" https://www.prnewswire.com/news-releases/eroll-grow-tech-seedo-merges-its-activities-with-grcr-partners-cannabics-pharmaceuticals-to-own-13-6-in-the-merged-company-300714621.html
The chart tells me this hits .20+ by end of Sept.
Update: ARCA ask is down to 15k at .198 :) They keep moving, but it's almost gone.
The ARCA ask at .197 is down to 19k =)
The PPS should settle over .20, up to.22. There are always false runs up and down, but that's a reasonable range until news breaks.
The ARCA ask at .197 is down to 36k shares. =) Hopefully it's a dam about to break. These are the same ARCA shares that have been pushing downward for the past week...
Pre-market on some weed stocks is way up++++
With weed booming, a run up over .22-.23+ today is very possible. Maybe much higher.
Weed giant Tilray hit a record high today. :)
I added 10,198 more shares earlier at .18, so, yeah... and that was all I had available.
The Ask side is shallow up to .22. :)
Anyone selling at these low prices is either a day-trader or someone that really doesn't understanding what they've got. Naturally, this is IMHO. I'm in. I'm not selling whether anyone else does or not, but I believe in the data, the people, and the products, so for me it's an easy decision. Due diligence at work.
Big cannabis is up 6% today on news... OWCP will also rebound.
I have to admit I'm surprised by the continuation up, and expected a drop back under .20. Naturally, I'm happy about it, and now realize it was not a one day run and retrace, but rather something far more interesting. This kind of buying is a serious signal of some as yet unknown positive force occurring and that bodes very well for we longs.